587 related articles for article (PubMed ID: 22264687)
21. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey.
Seitz DP; Gruneir A; Conn DK; Rochon PA
J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411
[TBL] [Abstract][Full Text] [Related]
22. Dementia and use of psychotropic medication in non-'Elderly Mentally Infirm' nursing homes in South East England.
Macdonald AJ; Carpenter GI; Box O; Roberts A; Sahu S
Age Ageing; 2002 Jan; 31(1):58-64. PubMed ID: 11850309
[TBL] [Abstract][Full Text] [Related]
23. Risk factors associated with the occurrence of fractures in U.S. nursing homes: resident and facility characteristics and prescription medications.
Spector W; Shaffer T; Potter DE; Correa-de-Araujo R; Rhona Limcangco M
J Am Geriatr Soc; 2007 Mar; 55(3):327-33. PubMed ID: 17341233
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
Gobert M; D'hoore W
Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
[TBL] [Abstract][Full Text] [Related]
25. Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership.
Coe AB; Zhang T; Zullo AR; Gerlach LB; Thomas KS; Daiello LA; Varma H; Lo D; Joshi R; Shireman TI; Bynum JPW
J Am Geriatr Soc; 2022 Dec; 70(12):3513-3525. PubMed ID: 35984088
[TBL] [Abstract][Full Text] [Related]
26. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia.
Sterke CS; van Beeck EF; van der Velde N; Ziere G; Petrovic M; Looman CW; van der Cammen TJ
J Clin Pharmacol; 2012 Jun; 52(6):947-55. PubMed ID: 21628599
[TBL] [Abstract][Full Text] [Related]
27. Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors.
Smeets CHW; Gerritsen DL; Zuidema SU; Teerenstra S; van der Spek K; Smalbrugge M; Koopmans RTCM
Aging Ment Health; 2018 Sep; 22(9):1239-1246. PubMed ID: 28726490
[TBL] [Abstract][Full Text] [Related]
28. Impact of an awareness of the doctors treating on the decrease of the prescriptions of antipsychotics in the demented residents in Ehpad.
Philippe AS; Braunstein D; Clot-Faybesse P; Teissier S; Roch B; Micallef J; Bonin-Guillaume S
Geriatr Psychol Neuropsychiatr Vieil; 2018 Dec; 16(4):383-390. PubMed ID: 30361189
[TBL] [Abstract][Full Text] [Related]
29. Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial.
Groot Kormelinck CM; van Teunenbroek CF; Kollen BJ; Reitsma M; Gerritsen DL; Smalbrugge M; Zuidema SU
BMC Psychiatry; 2019 Oct; 19(1):298. PubMed ID: 31606036
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis.
Jester DJ; Molinari V; Zgibor JC; Volicer L
Int Psychogeriatr; 2021 Oct; 33(10):1083-1098. PubMed ID: 33407955
[TBL] [Abstract][Full Text] [Related]
31. Geriatric drug utilisation of psychotropics in Belgian nursing homes.
Azermai M; Elseviers M; Petrovic M; Van Bortel L; Vander Stichele R
Hum Psychopharmacol; 2011 Jan; 26(1):12-20. PubMed ID: 21394786
[TBL] [Abstract][Full Text] [Related]
32. Persistent use of psychotropic drugs in nursing home residents in Norway.
Helvik AS; Šaltytė Benth J; Wu B; Engedal K; Selbæk G
BMC Geriatr; 2017 Feb; 17(1):52. PubMed ID: 28193181
[TBL] [Abstract][Full Text] [Related]
33. Organizational Factors Associated With Inappropriate Neuroleptic Drug Prescribing in Nursing Homes: A Multilevel Approach.
Laffon de Mazières C; Lapeyre-Mestre M; Vellas B; de Souto Barreto P; Rolland Y
J Am Med Dir Assoc; 2015 Jul; 16(7):590-7. PubMed ID: 25769961
[TBL] [Abstract][Full Text] [Related]
34. Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study.
Petek Šter M; Cedilnik Gorup E
Croat Med J; 2011 Feb; 52(1):16-24. PubMed ID: 21328716
[TBL] [Abstract][Full Text] [Related]
35. Prescribing pattern of psychotropic drugs in nursing home residents with dementia.
Wetzels RB; Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
Int Psychogeriatr; 2011 Oct; 23(8):1249-59. PubMed ID: 21682938
[TBL] [Abstract][Full Text] [Related]
36. Psychotropic drug prescriptions in Western European nursing homes.
Janus SI; van Manen JG; IJzerman MJ; Zuidema SU
Int Psychogeriatr; 2016 Nov; 28(11):1775-1790. PubMed ID: 27469071
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.
Avorn J; Soumerai SB; Everitt DE; Ross-Degnan D; Beers MH; Sherman D; Salem-Schatz SR; Fields D
N Engl J Med; 1992 Jul; 327(3):168-73. PubMed ID: 1608408
[TBL] [Abstract][Full Text] [Related]
38. Where Are Antipsychotics Prescribed in Nursing Homes Initiated?
Zhang Y; Letuchy EM; Carnahan RM
J Am Geriatr Soc; 2018 Jul; 66(6):1082-1088. PubMed ID: 29355891
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with psychotropic drug usage among nursing home residents with dementia.
Kim H; Whall AL
Nurs Res; 2006; 55(4):252-8. PubMed ID: 16849977
[TBL] [Abstract][Full Text] [Related]
40. The effects of group living homes on older people with dementia: a comparison with traditional nursing home care.
te Boekhorst S; Depla MF; de Lange J; Pot AM; Eefsting JA
Int J Geriatr Psychiatry; 2009 Sep; 24(9):970-8. PubMed ID: 19452499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
